Publication | Closed Access
Tocilizumab use in patients with moderate to severe COVID‐19: A retrospective cohort study
18
Citations
9
References
2020
Year
Tocilizumab and other IL-6 receptor monoclonal antibodies may evolve as a viable option in treating patients with moderate and severe COVID-19.
| Year | Citations | |
|---|---|---|
Page 1
Page 1